Jubilant Pharmova plans to raise Rs 800 crore via maiden bond issue
· Economic Times Markets
Jubilant Pharmova has announced plans to secure ₹800 crore via its first bond issuance within the local market, featuring ₹400 crore as the base amount and an equal greenshoe option. The capital raised will be primarily allocated to the company’s capital expenditure and upcoming expansion efforts.
The analysis
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- A market-wide development: it reaches beyond any single stock.
- Sectors in the story: Capital Goods & Engineering and Capital Markets.
Capital Goods & Engineering
1M -8.8% · 3M -4.8%
Capital Markets
1M -0.1% · 3M -5.1%
Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Sebi issues rules for depositary receipts on REITs, InvITs units
India's startup funding slows as global investors turn cautious, capital shifts to US
Sebi allows REITs, InvITs to tap overseas investors through depository receipts
We will consider the call for review of LTCG tax: Finance minister Nirmala Sitharaman
Muthoot FinCorp looks beyond gold loans with ₹3,000 crore IPO